A Big, Fatty Opportunity for Big Pharma The next multibillion-dollar therapeutic area for drug companies may be fatty liver disease, but ...
A Big, Fatty Opportunity for Big Pharma The next multibillion-dollar therapeutic area for drug companies may be fatty liver disease, but ...
US banks wake up to an easy money hangover Balance sheets are strong, but business is going to become tougher The editorial board Ci...
How US Monetary Policy Has Tamed China In any emerging economy, there is an important connection between the health of the capital accoun...
The Trump Administration’s Farewell to Aims Whereas previous US political leaders used speeches in Cairo to explain America's broad o...
Legalising marijuana in the US: the economic highs (and lows) Wall Street is rushing into a field already worth an estimated $10bn Gill...
Why Trump’s America is rethinking engagement with China The more aggressive US approach is part of a strategic shift that goes well beyon...
Innovation How the Blockchain Ushers in a New Form of Trust Blockchain is one of the biggest buzzwords in technology today. But confus...
Wary investors drawn to gold’s allure Central-bank buying pushes prices higher after two tough years for gold bugs Henry Sanderson and ...
The World Is Drowning in Debt By Reshma Kapadia Joel Arbaje; Source Photograph by Bill Jelen There is much they quarrel about. ...